Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

845
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
845
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

649
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
649
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

408
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
408
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

518
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
518
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

499
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
499
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

906
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
906

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex related long-term outcomes in on-pump coronary artery bypass grafting-A propensity score-matched analysis.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Circulating biomarkers improve prediction of postoperative outcome after aortic valve surgery.

Frontiers in cardiovascular medicine·2026
Same author

Noncontrast transcatheter aortic valve implantation technique with balloon-expandable prostheses.

JTCVS structural and endovascular·2026
Same author

Acute and midterm outcomes of patients undergoing right-sided heart valve surgery for carcinoid heart valve disease.

JTCVS techniques·2026
Same author

Undiagnosed Thoracic Aortic Aneurysms: Prevalence, Risk Factors, Screening Modalities.

Deutsches Arzteblatt international·2026
Same author

Sex-Related Outcome After Sutureless Aortic Valve Replacement With Perceval Plus: Results From a Global Registry and Meta-Regression.

Interdisciplinary cardiovascular and thoracic surgery·2026

Related Experiment Video

Updated: Feb 24, 2026

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

1.6K

Update on bicuspid aortic valve aortopathy.

Evaldas Girdauskas1, Johannes Petersen

  • 1Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany.

Current Opinion in Cardiology
|August 11, 2017
PubMed
Summary

New biomarkers show promise for predicting thoracic aortic aneurysm progression in patients with bicuspid aortic valve (BAV) disease. Combining these with imaging and risk factors can improve diagnosis and care.

More Related Videos

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.7K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.7K

Related Experiment Videos

Last Updated: Feb 24, 2026

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

1.6K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.7K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.7K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Biomarker Discovery

Background:

  • Bicuspid aortic valve (BAV) associated aortopathy treatment remains controversial.
  • Current research focuses on predicting disease progression and adverse aortic events.

Purpose of the Study:

  • To summarize recent evidence on predicting aortopathy progression in BAV disease.
  • To identify novel markers for adverse aortic events.

Main Methods:

  • Literature review of recent studies.
  • Analysis of hemodynamic and blood-born biomarkers.
  • Exploration of genetic analyses.

Main Results:

  • Hemodynamic markers are key to understanding BAV-associated aortopathy progression.
  • Blood-born biomarkers offer a promising approach for predicting adverse aortic events.
  • Genetic factors are under investigation.

Conclusions:

  • Serological biomarkers are valuable for screening and predicting thoracic aortic aneurysmal disease.
  • Integrating biomarkers with rheological imaging and risk factors enhances diagnostic accuracy and cost-effectiveness for BAV-associated aortopathy.